InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Staten Christopher, Chief Financial Officer. Director active across 1 company, notably Aerie Pharmaceuticals INC. Aggregated, 1 reports have been recorded. Activity tracked since 14 August 2021. The latest transaction was filed on 14 August 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Christopher Staten is the Interim CFO of AERIE PHARMACEUTICALS INC. He oversees the financial management of the company during the transition period. Christopher plays a key role in ensuring continuity in financial operations.